ΨΥΧΟΛΟΓΙΑ - Έρευνα και Εφαρμογές ΤΕΥΧΟΣ 3 | Page 13

«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
23. Genomewide Association for Schizophrenia in the CATIE Study: Results of
Stage 1 Patrick F. Sullivan, MD, FRANZCP,1,2 Danyu Lin, PhD,3 Jung-Ying Tzeng,
PhD,4 Edwin van den Oord, PhD,5 Diana Perkins, MD,6 T. Scott Stroup, MD,6
Michael Wagner, PhD,7 Seunggeun Lee,3 Fred A. Wright, PhD,3 Fei Zou, PhD,3
Wenlei Liu, PhD,8 AnnCatherine M. Downing, PharmD,9 Jeffrey Lieberman, MD,10
and Sandra L. Close, PhD9. Mol Psychiatry. 2008 Jun; 13(6): 570–584.
24. Genome-wide association studies (GWAS) of schizophrenia: does bigger lead to
better results? Sarah E. Bergen, PhD and Tracey L. Petryshen, PhD
25. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-
B alleles Jacqueline I Goldstein, L Fredrik Jarskog,Chris Hilliard, Ana Alfirevic,
Laramie Duncan, Denis Fourches, Hailiang Huang, Monkol Lek, Benjamin M Neale,
Stephan Ripke, Kevin Shianna, Jin P Szatkiewicz, Alexander Tropsha, Edwin JCG
van den Oord, Ingolf Cascorbi, Michael Dettling, Ephraim Gazit, Donald C Goff,
Arthur L Holden, Deanna L Kelly, Anil K Malhotra, Jimmi Nielsen, Munir
Pirmohamed, Dan Rujescu, Thomas Werge, Deborah L Levy, Richard C Josiassen,
James L Kennedy, Jeffrey A Lieberman, Mark J Daly, and Patrick F Sullivan, Nat
Commun. 2014; 5: 4757.
26. Pharmacogenetics of antidepressant response Stefano Porcelli, MD, Antonio
Drago, MD, Chiara Fabbri, Sara Gibiino, MD, Raffaella Calati, PsyD, PhD, and
Alessandro Serretti, MD, PhD. J Psychiatry Neurosci. 2011 Mar; 36(2): 87–113.
27. Psychiatric Pharmacogenomics, David Mrazek, chapter 6, page 75
28. The ABCB1 transporter gene and antidepressant response Eric J Peters, Victor
Reus, Ste29. Influence of tryptophan hydroxylase and serotonin transporter genes
on fluvoxamine antidepressant activity. Serretti, Zanardi R, Rossini D, Cusin C, Lilli
R, Smeraldi E. Mol Psychiatry. 2001 Sep;6(5):586-92ven P Hamilton, F1000 Biol
Rep. 200; 1: 23.
30. Catechol O-methyltransferase pharmacogenomics and selective serotonin
reuptake inhibitor response Yuan Ji, Joanna Biernacka, Karen Snyder, Maureen
Drews, Linda L. Pelleymounter, Colin Colby, Liewei Wang, David A. Mrazek, and
Richard M. Weinshilboum
31. Association of the COMT val158met variant with antidepressant treatment
response in major depression. Baune BT1, Hohoff C, Berger K, Neumann A,
Mortensen
S,
Roehrs
T,
Deckert
J,
Arolt
V,
Domschke
K.
Neuropsychopharmacology. 2008 Mar;33(4):924-32. Epub 2007 May 23.
32. Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene
polymorphism and antidepressant response to fluvoxamine in Japanese patients
with major depressive disorder. Yoshida K1, Naito S, Takahashi H, Sato K, Ito K,
Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T,
Sugawara K, Otani K. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Dec;26(7-
8):1279-83.
33. From Pharmacogenetics to Pharmacogenomics: The Way Toward the
Personalization of Antidepressant Treatment Chiara Fabbri, Stefano Porcelli, and
Alessandro Serretti, Can J Psychiatry. 2014 Feb; 59(2): 62–75.